Fusing Docking Scoring Functions Improves the Virtual Screening Performance for Discovering Parkinson's Disease Dual Target Ligands-Reference-Cited by-同舟云学术

Fusing Docking Scoring Functions Improves the Virtual Screening Performance for Discovering Parkinson's Disease Dual Target Ligands

Published:2017-11-14 Issue:8 Volume:15 Page:
ISSN:1570-159X
Container-title:Current Neuropharmacology
language:en
Short-container-title:CN

Author:

Perez-Castillo Yunierkis¹,Helguera Aliuska Morales²,Cordeiro M.Natalia D. S.³,Tejera Eduardo⁴,Paz-y-Mino Cesar⁴,Sanchez-Rodriguez Aminael⁵,Borges Fernanda⁶,Cruz-Monteagudo Maykel⁴

Affiliation:

1. Departamento de Quimica. Universidad Tecnica Particular de Loja. Loja, Ecuador

2. Molecular Simulation and Drug Design Group, Centro de Bioactivos Quimicos (CBQ), Universidad Central “Marta Abreu” de Las Villas, Santa Clara, 54830, Cuba

3. REQUIMTE, Department of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, 4169-007 Porto, Portugal

4. Instituto de Investigaciones Biomedicas (IIB), Universidad de Las Americas, 170513 Quito, Ecuador

5. Departamento de Ciencias Naturales, Universidad Tecnica Particular de Loja, Calle París S/N, EC1101608 Loja, Ecuador

6. CIQUP/Departamento de Quimica e Bioquimica, Faculdade de Ciencias, Universidade do Porto, Porto 4169-007, Portugal

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmacology (medical),Psychiatry and Mental health,Neurology (clinical),Neurology,Pharmacology,General Medicine

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hit Identification Driven by Combining Artificial Intelligence and Computational Chemistry Methods: A PI5P4K-β Case Study;Journal of Chemical Information and Modeling;2023-08-07

2. In Silico Identification of Multi-Target Ligands as Promising Hit Compounds for Neurodegenerative Diseases Drug Development;International Journal of Molecular Sciences;2022-11-07

3. Maximizing the integration of virtual and experimental screening in hit discovery;Expert Opinion on Drug Discovery;2022-06-03

4. A human-based multi-gene signature enables quantitative drug repurposing for metabolic disease;ELIFE;2022

5. A human-based multi-gene signature enables quantitative drug repurposing for metabolic disease;eLife;2022-01-17